U.S. Department of Justice Civil Division Press Releases Update

You are subscribed to Civil Division Press Releases for U.S. Department of Justice. This information has recently been updated, and is now available.

Pharmaceutical Company QOL Medical and CEO Agree to Pay $47M for Allegedly Paying Kickbacks to Induce Claims for QOL's Drug Sucraid

11/15/2024 07:00 AM EST

Pharmaceutical company QOL Medical LLC (QOL) and its co-owner and CEO, Frederick E. Cooper, have agreed to pay $47 million to resolve allegations that they caused the submission of false claims to federal health care programs, in violation of the False Claims Act and similar state statutes, by offering kickbacks in the form of free Carbon-13 breath testing services to induce claims for QOL's drug Sucraid.

---

     

---

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice website. GovDelivery is providing this service on behalf of the Department of Justice 950 Pennsylvania Ave., NW · Washington, DC 20530 · 202-514-2000 and may not use your subscription information for any other purposes.

Manage your Subscriptions | Department of Justice Privacy Policy  | GovDelivery Privacy Policy